Enthusiasm for diagnostic tests: Health effects and their surveillance. 2008 SESPAS report;El entusiasmo por las pruebas diagnósticas: Efectos en la salud y formas de control. Informe SESPAS 2008

Gaceta Sanitaria

Volumn 22, Issue SUPPL. 1, 2008, Pages 216-222

  Lumbreras, Blanca ^a   Aguado, Ildefonso Hernández ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Adverse effects; Diagnostic test; Evidence based diagnosis

Indexed keywords

EID: 45149113862     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1016/s0213-9111(08)76095-3     Document Type: Review

References (60)

1. Márquez S, Meneu R. La medicalización de la vida y sus protagonistas. Gest Clin Sanit. 2003;2:47-53.
2. Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA. 1999;281:446-53.
3. Winkens R, Dinant GJ. Evidence base of clinical diagnosis: Rational, cost effective use of investigations in clinical practice. BMJ. 2002;324:783.
4. Leurquin P, Van Casteren V, De Maeseneer J. Use of blood tests in general practice: a collaborative study in eight European countries. Eurosentinel Study Group. Br J Gen Pract. 1995;45:21-5.
5. Ayanian JZ, Berwick DM. Do physicians have a bias toward action? A classic study revisited. Med Decis Making. 1991;11:154-8.
6. Lee TH, Brennan TA. Direct-to-consumer marketing of high-technology screening tests. N Engl J Med. 2002;346:529-31.
7. Gollust SE, Hull SC, Wilfond BS. Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA. 2002;288:1762-7.
8. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291:71-8.
9. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993;328:1237-43.
10. Rogers J. The finished genome sequence of Homo sapiens. Cold Spring Harb Symp Quant Biol. 2003;68:1-11.
11. Milunsky A. Commercialization of clinical genetic laboratory services: in whose best interest? Obstet Gynecol. 1993;81:627-9.
12. Korf BR. Advances in molecular diagnosis. Curr Opin Obstet Gynecol. 1996;8:130-4.
13. Barratt A, Howard K, Irwig L, Salkeld G, Houssami N. Model of outcomes of screening mammography: information to support informed choices. BMJ. 2005;330:936.
14. Castells X, Molins E, Macià F. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme. J Epidemiol Community Health. 2006;60:316-21.
15. Mayor S. Women with early breast cancer to be tested for trastuzumab treatment. BMJ. 2005;331:864.
16. Raffle AE, Quinn M. Harms and benefits of screening to prevent cervical cancer. Lancet. 2004;364:1483-4.
17. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA. 2007;297:953-61.
18. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS; International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763-71.
19. Pérez-Fernández M, Gérvas J. Cascade effect: clinical, epidemiological and ethical implications. Med Clin (Barc). 2002;118:65-7.
20. Mold JW, Stein HF. The cascade effect in the clinical care of patients. N Engl J Med. 1986;314:512-4.
21. Deyo RA. Cascade effects of medical technology. Annu Rev Public Health. 2002;23:23-44.
22. Chidiac RM, Aron DC. Incidentalomas. A disease of modern technology. Endocrinol Metab Clin North Am. 1997;26:233-53.
23. Aron DC, Howlett TA. Pituitary incidentalomas. Endocrinol Metab Clin North Am. 2000;29:205-21.
24. Cano-Serral G, Rodríguez-Sanz M, Borrell C, Pérez MM, Salvador J. Desigualdades socioeconómicas relacionadas con el cuidado y el control del embarazo. Gac Sanit. 2006;20:25-30.
25. Porta M, Hernández-Aguado I. ¿Hacer más o mejor lo que hay que hacer? EIDON. En prensa 2008.
26. Van Walraven C, Raymond M. Population-based study of repeat laboratory testing. Clin Chem. 2003;49:1997-2005.
27. Silverstein DS, Livingston DH, Elcavage J, Kovar L, Kelly KM. The utility of routine daily chest radiography in the surgical intensive care unit. J Trauma. 1993;35:643-6.
28. Weydert JA, Nobbs ND, Feld R, Kemp JD. A simple, focused, computerized query to detect overutilization of laboratory tests. Arch Pathol Lab Med. 2005;129:1141-3.
29. Bates DW, Boyle DL, Rittenberg E, Kuperman GJ, Ma'Luf N, Menkin V, et al What proportion of common diagnostic tests appears redundant? Am J Med. 1998;104:361-8.
30. Dale JC, Ruby SG. Specimen collection volumes for laboratory tests. Arch Pathol Lab Med. 2003;127:162-8.
31. Eddy DM, editor. Common screening tests. Philadelphia: American College of Physicians; 1991.
32. Hernández-Aguado I. The winding road towards evidence based diagnoses. J Epidemiol Community Health. 2002;56:323-5.
33. Bunting PS, Van Walraven C. Effect of a controlled feedback intervention on laboratory test ordering by community physicians. Clin Chem. 2004;50:321-6.
34. Winkens RA, Ament AJ, Pop P, Reniers PH, Grol RP, Knottnerus JA. Routine individual feedback on requests for diagnostic tests: an economic evaluation. Med Decis Making. 1996;16:309-14.
35. Winkens RA, Pop P, Grol RP, Kester AD, Knottnerus JA. Effect of feedback on test ordering behaviour of general practitioners. BMJ. 1992;304:1093-6.
36. Variabilidad en la solicitud de pruebas de laboratorio. Uso innecesario y estrategias de gestión de la utilización. Var Pract Med. 1997;12:1-5.
37. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med. 1993;329:1271-3.
38. Zaat JO, Van Eijk JT, Bonte HA. Laboratory test form design influences test ordering by general practitioners in The Netherlands. Med Care. 1992;30:189-98.
39. Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behaviour or health care outcomes? JAMA. 1999;282:867-74.
40. Jamtvedt G, Young JM. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2003;3:CD000259.
41. Solomon DH, Hashimoto H, Daltroy L, Liang MH. Techniques to improve physicians' use of diagnostic tests: a new conceptual framework. JAMA 1998;280:2020-7.
42. Emerson JF, Emerson SS. The impact of requisition design on laboratory utilization. Am J Clin Pathol. 2001;116:879-84.
43. Winkens RA, Grol RP, Beusmans GH, Kester AD, Knottnerus JA, Pop P. Does a reduction in general practitioners' use of diagnostic tests lead to more hospital referrals? Br J Gen Pract. 1995;45:289-92.
44. Flood AB, Wennberg JE, Nease RF Jr, Fowler FJ Jr, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996;11:342-9.
45. Lumbreras-Lacarra B, Ramos-Rincon JM, Hernández-Aguado I. Methodology in diagnostic laboratory test research in clinical chemistry and clinical chemistry and laboratory medicine. Clin Chem. 2004;50:530-6.
46. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA. 1995;274:645-51.
47. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, Van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282:1061-6.
48. Ramos Rincon JM, Hernández Aguado I. Research on diagnostic tests in medicina clinica. A methodological assessment. Med Clin (Barc). 1998;111:129-34.
49. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem. 2003;49:1-6.
50. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
51. Smidt N, Rutjes AW, Van der Windt DA, Ostelo RW, Reitsma JB, Bossuyt PM, et al. Quality of reporting of diagnostic accuracy studies. Radiology. 2005;235:347-53.
52. Nakhleh RE, Gephardt G, Zarbo RJ. Necessity of clinical information in surgical pathology. Arch Pathol Lab Med. 1999;123:615-9.
53. Murakata LA, Lewin-Smith MR, Specht CS, Kalasinsky VF, McEvoy PL, Vinh TN, et al. Characterization of acrylic polyamide plastic embolization particles in vitro and in human tissue sections by light microscopy, infrared microspectroscopy and scanning electron microscopy with energy dispersive X-ray analysis. Mod Pathol. 2006;19:922-30.
54. Burke W, Atkins D, Gwinn M, Guttmacher A, Haddow J, Lau J, et al. Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol. 2002;156:311-8.
55. Márquez S, Briones E. Marco para la evaluación de pruebas genéticas en el Sistema Sanitario Público de Andalucía. Sevilla: AETSA; 2005. Informe 2/2005.
56. Nico P, Van Duijn CM. Predictive values instead of normal ranges: less data, more information. Accred Qual Assur. 2006;11:269-72.
57. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia: W.B. Saunders Company; 1985.
58. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001;93:1054-61.
59. Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ. 1986;134:587-94.
60. Mackenzie R, Dixon AK. Measuring the effects of imaging: an evaluative framework. Clin Radiol. 1995;50:513-8.